Chuanqi Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chuanqi Sun has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Lin Jiang
Department of Neurology, Molecular Biology Institute and Brain Research Institute, UCLA, Los Angeles, CA, USA.
2 shared publications - Z. Hong Zhou
California NanoSystems Institute, University of California, Los Angeles, CA 90095, USA
2 shared publications Cally Li
California NanoSystems Institute, UCLA, Los Angeles, California, USA; Alsion Montessori High School, Fremont, California, USA
1 shared publicationChao Peng
Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA
1 shared publication- Chao Peng
Department of Neurology David Geffen School of Medicine University of California Los Angeles Los Angeles CA 90095 USA
1 shared publication - Haoyu Zhang
Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA
1 shared publication
Latest Publications
- Open Access
- 2 January 2026
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 21 (9) , 4257-4258
Alpha-synuclein structural variants driving tau pathology and disease interaction
- 2 January 2026
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 21 (9) , 4257-4258
Open AccessAlpha-synuclein structural variants driving tau pathology and disease interaction
- Open Access
AI-Guided Dual Strategy for Peptide Inhibitor Design Targeting Structural Polymorphs of α-Synuclein Fibrils
One of the most important events in the pathogenesis of Parkinson’s disease and related disorders is the formation of abnormal fibrils via the aggregation of α-synuclein (α-syn) with β-sheet-rich organization. The use of Cryo-EM has uncovered different polymorphs of the fibrils, each having unique structural interfaces, which has made the design of inhibitors even more challenging. Here, a structure-guided framework incorporating AI-assisted peptide generation was set up with the objective of targeting the conserved β-sheet motifs that are present in various forms of α-syn fibrils. The ProteinMPNN, then, AlphaFold-Multimer, and PepMLM were employed to create short peptides that would interfere with the growth of the fibrils. The two selected candidates, T1 and S1, showed a significant inhibition of α-syn fibrillation, as measured by a decrease in the ThT fluorescence and the generation of either amorphous or fragmented aggregates. The inhibitory potency of the peptides was in line with the predicted interface energies. This research work illustrates that the integration of cryo-EM structural knowledge with the computational design method leads to the quick discovery of the wide-spectrum peptide inhibitors, which is a good strategy for the precision treatment of neurodegenerative diseases.
Open AccessAI-Guided Dual Strategy for Peptide Inhibitor Design Targeting Structural Polymorphs of α-Synuclein Fibrils
One of the most important events in the pathogenesis of Parkinson’s disease and related disorders is the formation of abnormal fibrils via the aggregation of α-synuclein (α-syn) with β-sheet-rich organization. The use of Cryo-EM has uncovered different polymorphs of the fibrils, each having unique structural interfaces, which has made the design of inhibitors even more challenging. Here, a structure-guided framework incorporating AI-assisted peptide generation was set up with the objective of targeting the conserved β-sheet motifs that are present in various forms of α-syn fibrils. The ProteinMPNN, then, AlphaFold-Multimer, and PepMLM were employed to create short peptides that would interfere with the growth of the fibrils. The two selected candidates, T1 and S1, showed a significant inhibition of α-syn fibrillation, as measured by a decrease in the ThT fluorescence and the generation of either amorphous or fragmented aggregates. The inhibitory potency of the peptides was in line with the predicted interface energies. This research work illustrates that the integration of cryo-EM structural knowledge with the computational design method leads to the quick discovery of the wide-spectrum peptide inhibitors, which is a good strategy for the precision treatment of neurodegenerative diseases.
- Open Access
- 8 September 2025
- Published by EMBL-EBI
CryoEM data of alpha-synuclein fibril induced by psychosine
- 8 September 2025
- Published by EMBL-EBI
Open AccessCryoEM data of alpha-synuclein fibril induced by psychosine
- Open Access
- 25 February 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (4) , 108351
Structural basis of a distinct α-synuclein strain that promotes tau inclusion in neurons
- 25 February 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (4) , 108351
Open AccessStructural basis of a distinct α-synuclein strain that promotes tau inclusion in neurons
- Open Access
- 5 March 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (4) , 104566
Cryo-EM structure of amyloid fibril formed by α-synuclein hereditary A53E mutation reveals a distinct protofilament interface
- 5 March 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (4) , 104566
Open AccessCryo-EM structure of amyloid fibril formed by α-synuclein hereditary A53E mutation reveals a distinct protofilament interface